SITE009-0168

SITE009 (AUS) › SITE009-0168

SITE009-0168

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-03-25

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-18 (study day 146); relationship: not assessed

moderate assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-09 (study day 45); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.